Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Discovery of N2-(4-Amino-cyclohexyl)-9-cyclopentyl- N6-(4-morpholin-4-ylmethyl-phenyl)- 9H-purine-2,6-diamine as a Potent FLT3 Kinase Inhibitor for Acute Myeloid Leukemia with FLT3 Mutations

T. Gucký, E. Řezníčková, T. Radošová Muchová, R. Jorda, Z. Klejová, V. Malínková, K. Berka, V. Bazgier, H. Ajani, M. Lepšík, V. Divoký, V. Kryštof,

. 2018 ; 61 (9) : 3855-3869. [pub] 20180430

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028475

Grantová podpora
NV15-28951A MZ0 CEP - Centrální evidence projektů

FLT3 tyrosine kinase is a potential drug target in acute myeloid leukemia (AML) because patients with FLT3-ITD mutations respond poorly to standard cytotoxic agents and there is a clear link between the disease and the oncogenic properties of FLT3. We present novel 2,6,9-trisubstituted purine derivatives with potent FLT3 inhibitory activity. The lead compound 7d displays nanomolar activity in biochemical assays and selectively blocks proliferation of AML cell lines harboring FLT3-ITD mutations, whereas other transformed and normal human cells are several orders of magnitude less sensitive. The MV4-11 cells treated with 7d suppressed the phosphorylation of FLT3 and its downstream signaling pathways, with subsequent G1 cell cycle arrest and apoptosis. Additionally, a single dose of 7d in mice with subcutaneous MV4-11 xenografts caused sustained inhibition of FLT3 and STAT5 phosphorylation over 48 h, in contrast to the shorter effect observed after administration of the reference FLT3 inhibitor quizartinib.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028475
003      
CZ-PrNML
005      
20211207134801.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.jmedchem.7b01529 $2 doi
035    __
$a (PubMed)29672049
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gucký, Tomáš, $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Faculty of Science , Palacký University , Šlechtitelů 27 , 783 71 Olomouc , Czech Republic. $d 1978- $7 ola2005284374
245    10
$a Discovery of N2-(4-Amino-cyclohexyl)-9-cyclopentyl- N6-(4-morpholin-4-ylmethyl-phenyl)- 9H-purine-2,6-diamine as a Potent FLT3 Kinase Inhibitor for Acute Myeloid Leukemia with FLT3 Mutations / $c T. Gucký, E. Řezníčková, T. Radošová Muchová, R. Jorda, Z. Klejová, V. Malínková, K. Berka, V. Bazgier, H. Ajani, M. Lepšík, V. Divoký, V. Kryštof,
520    9_
$a FLT3 tyrosine kinase is a potential drug target in acute myeloid leukemia (AML) because patients with FLT3-ITD mutations respond poorly to standard cytotoxic agents and there is a clear link between the disease and the oncogenic properties of FLT3. We present novel 2,6,9-trisubstituted purine derivatives with potent FLT3 inhibitory activity. The lead compound 7d displays nanomolar activity in biochemical assays and selectively blocks proliferation of AML cell lines harboring FLT3-ITD mutations, whereas other transformed and normal human cells are several orders of magnitude less sensitive. The MV4-11 cells treated with 7d suppressed the phosphorylation of FLT3 and its downstream signaling pathways, with subsequent G1 cell cycle arrest and apoptosis. Additionally, a single dose of 7d in mice with subcutaneous MV4-11 xenografts caused sustained inhibition of FLT3 and STAT5 phosphorylation over 48 h, in contrast to the shorter effect observed after administration of the reference FLT3 inhibitor quizartinib.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x chemie $x metabolismus $x farmakologie $7 D000970
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a diaminy $x chemie $x metabolismus $x farmakologie $7 D003959
650    12
$a objevování léků $7 D055808
650    _2
$a akutní myeloidní leukemie $x genetika $x patologie $7 D015470
650    _2
$a myši $7 D051379
650    _2
$a simulace molekulového dockingu $7 D062105
650    _2
$a konformace proteinů $7 D011487
650    _2
$a inhibitory proteinkinas $x chemie $x metabolismus $x farmakologie $7 D047428
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a xenogenní modely - testy protinádorové aktivity $7 D023041
650    _2
$a tyrosinkinasa 3 podobná fms $x antagonisté a inhibitory $x chemie $x genetika $x metabolismus $7 D051941
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Řezníčková, Eva $u Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research , Palacký University and Institute of Experimental Botany AS CR , Šlechtitelů 27 , 783 71 Olomouc , Czech Republic.
700    1_
$a Radošová Muchová, Tereza $u Department of Biology, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 3 , 775 15 Olomouc , Czech Republic.
700    1_
$a Jorda, Radek $u Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research , Palacký University and Institute of Experimental Botany AS CR , Šlechtitelů 27 , 783 71 Olomouc , Czech Republic.
700    1_
$a Klejová, Zuzana $u Department of Biology, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 3 , 775 15 Olomouc , Czech Republic.
700    1_
$a Malínková, Veronika $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Faculty of Science , Palacký University , Šlechtitelů 27 , 783 71 Olomouc , Czech Republic.
700    1_
$a Berka, Karel $u Department of Physical Chemistry, Regional Centre of Advanced Technologies and Materials, Faculty of Science , Palacky University , 17. listopadu 12 , 771 46 Olomouc , Czech Republic.
700    1_
$a Bazgier, Václav, $u Department of Physical Chemistry, Regional Centre of Advanced Technologies and Materials, Faculty of Science , Palacky University , 17. listopadu 12 , 771 46 Olomouc , Czech Republic. $d 1982- $7 ola2015878480
700    1_
$a Ajani, Haresh $u Department of Physical Chemistry, Regional Centre of Advanced Technologies and Materials, Faculty of Science , Palacky University , 17. listopadu 12 , 771 46 Olomouc , Czech Republic. Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 166 10 Prague 6 , Czech Republic.
700    1_
$a Lepšík, Martin $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 166 10 Prague 6 , Czech Republic.
700    1_
$a Divoký, Vladimír $u Department of Biology, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 3 , 775 15 Olomouc , Czech Republic.
700    1_
$a Kryštof, Vladimír $u Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research , Palacký University and Institute of Experimental Botany AS CR , Šlechtitelů 27 , 783 71 Olomouc , Czech Republic.
773    0_
$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 61, č. 9 (2018), s. 3855-3869
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29672049 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20211207134759 $b ABA008
999    __
$a ok $b bmc $g 1433624 $s 1066935
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 61 $c 9 $d 3855-3869 $e 20180430 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
GRA    __
$a NV15-28951A $p MZ0
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace